- Home
- AADI
AADI
Aadi Bioscience Inc.
as 11-15-2024 4:00pm EST
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | PACIFIC PALISADES |
| Market Cap: | 49.0M | IPO Year: | N/A |
| Target Price: | $1.75 | AVG Volume (30 days): | 114.7K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.21 - $5.70 | Next Earning Date: | 11-06-2024 |
| Revenue: | $25,070,000 | Revenue Growth: | 7.80% |
| Revenue Growth (this year): | 8.1% | Revenue Growth (next year): | 8.54% |
Stock Insider Trading Activity of Aadi Bioscience Inc. (AADI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lennon David James | AADI | CHIEF EXECUTIVE OFFICER | Oct 2 '24 | Sell | $1.94 | 9,689 | $18,796.66 | 22,869 | |
| Desai Neil | AADI | EXECUTIVE CHAIRMAN | Sep 3 '24 | Sell | $1.71 | 40,000 | $68,316.00 | 1,171,543 |
Latest Aadi Bioscience Inc. News
AADI Breaking Stock News: Dive into AADI Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
US Penny Stocks Under $90M Market Cap To Watch
PR Newswire
11 days ago
Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
PR Newswire
18 days ago
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update
PR Newswire
3 months ago
Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates
PR Newswire
3 months ago
Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update
PR Newswire
4 months ago
Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update
Simply Wall St.
4 months ago
We're Keeping An Eye On Aadi Bioscience's (NASDAQ:AADI) Cash Burn Rate
Motley Fool
5 months ago
Better AI Stock: Palantir vs. Snowflake
Compare AADI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AADI Aadi Bioscience Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.